IINN
Inspira Technologies Oxy B.H.N. Ltd.·Healthcare
1.52
109.078%(+0.79)
Close PriceLast Updated: — ET
52W L: $0.3352W H: $1.65
IINN NEWS
globenewswire.com
6d ago
QTREX in Advanced Discussions with Top-Five Global Quantum Computing Company Regarding Strategic Collaboration
Nes Ziona, Israel, May 21, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a developer of additively manufactured electronics ("AME") technologies for cryogenic interconnect and quantum hardware infrastructure, today announced that it is in advanced discussions with one of the top five companies globally in quantum computing systems regarding a strategic collaboration agreement.
globenewswire.com
May 19
Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity
RA'ANANA, Israel, May 19, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that, at the opening of trading on the Nasdaq Capital Market on May 20, 2026, the Company's ordinary shares will begin trading under the new ticker symbol "QTEX" in connection with the Company's corporate name change to QTREX Quantum Ltd.
globenewswire.com
May 18
NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation
RA'ANANA, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that it has received a $580,000 commercial purchase order from NYU Langone Hospital in New York City (“NYU Langone”) for the Company's FDA-cleared ART100 extracorporeal blood circulation systems. The order was placed through Inspira's U.S. distributor following the successful completion of a multi-patient clinical evaluation at the hospital, and the systems are scheduled for immediate fulfillment. This commercial milestone is in parallel with the Company's previously disclosed active strategic process involving the ART100 platform and broader medical assets.
globenewswire.com
May 11
Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan
RA'ANANA, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B. H. N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," "Inspira Technologies," or the "Company"), today issued a letter to its shareholders from its Chief Executive Officer, Dagi Ben-Noon.
globenewswire.com
May 11
Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan
RA'ANANA, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," "Inspira Technologies," or the "Company"), today issued a letter to its shareholders from its Chief Executive Officer, Dagi Ben-Noon.
globenewswire.com
May 1
Inspira Secures $596,000 AME System Order from Leading Irish Technological University
RA'ANANA, Israel, May 01, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that it has secured a $596,000 purchase order for an Additively Manufactured Electronics ("AME") system from a leading Irish technological research university. The order is structured with a non-refundable upfront payment of 40% of the order value, which has been received by the Company, with the balance payable against delivery.
